1. Differential modulation of white adipose tissue endocannabinoid levels by n-3 fatty acids in obese mice and type 2 diabetic patients.
- Author
-
Rossmeisl, Martin, Pavlisova, Jana, Janovska, Petra, Kuda, Ondrej, Bardova, Kristina, Hansikova, Jana, Svobodova, Michaela, Oseeva, Marina, Veleba, Jiri, JrKopecky, Jan, Zacek, Petr, Fiserova, Eva, Pelikanova, Terezie, and Kopecky, Jan
- Subjects
- *
ADIPOSE tissues , *CANNABINOIDS , *FATTY acids , *LABORATORY mice , *TYPE 2 diabetes - Abstract
n-3 polyunsaturated fatty acids ( n-3 PUFA ) might regulate metabolism by lowering endocannabinoid levels. We examined time-dependent changes in adipose tissue levels of endocannabinoids as well as in parameters of glucose homeostasis induced by n-3 PUFA in dietary-obese mice, and compared these results with the effect of n-3 PUFA intervention in type 2 diabetic (T2DM) subjects. Male C57BL/6J mice were fed for 8, 16 or 24 weeks a high-fat diet alone (cHF) or supplemented with n-3 PUFA (cHF + F). Overweight/obese, T2DM patients on metformin therapy were given for 24 weeks corn oil (Placebo; 5 g/day) or n-3 PUFA concentrate as above (Omega-3; 5 g/day). Endocannabinoids were measured by liquid chromatography-tandem mass-spectrometry. Compared to cHF-fed controls, the cHF + F mice consistently reduced 2-arachidonoylglycerol (up to ~2-fold at week 24) and anandamide (~2-fold) in adipose tissue, while the levels of endocannabinoid-related anti-inflammatory molecules N -eicosapentaenoyl ethanolamine (EPEA) and N -docosahexaenoyl ethanolamine (DHEA) increased more than ~10-fold and ~8-fold, respectively. At week 24, the cHF + F mice improved glucose tolerance and fasting blood glucose, the latter being positively correlated with adipose 2-arachidonoylglycerol levels only in obese cHF-fed controls, like fasting insulin and HOMA-IR. In the patients, n-3 PUFA failed to reduce 2-arachidonoylglycerol and anandamide levels in adipose tissue and serum, but they increased both adipose tissue and serum levels of EPEA and DHEA. In conclusion, the inability of n-3 PUFA to reduce adipose tissue and serum levels of classical endocannabinoids might contribute to a lack of beneficial effects of these lipids on glucose homeostasis in T2DM patients. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF